Your browser doesn't support javascript.
loading
Natural product 1,2,3,4,6-penta-O-galloyl-ß-D-glucopyranose is a reversible inhibitor of glyceraldehyde 3-phosphate dehydrogenase.
Li, Wen; Liao, Li-Ping; Song, Ning; Liu, Yan-Jun; Ding, Yi-Luan; Zhang, Yuan-Yuan; Zhou, Xiao-Ru; Sun, Zhong-Ya; Xiao, Sen-Hao; Wang, Hong-Bo; Lu, Jing; Zhang, Nai-Xia; Jiang, Hua-Liang; Chen, Kai-Xian; Liu, Chuan-Peng; Zheng, Jie; Zhao, Ke-Hao; Luo, Cheng.
Affiliation
  • Li W; School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, China.
  • Liao LP; Drug Discovery and Design Center, the Center for Chemical Biology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Song N; University of Chinese Academy of Sciences, Beijing, 100049, China.
  • Liu YJ; University of Chinese Academy of Sciences, Beijing, 100049, China.
  • Ding YL; Center of Immunological Diseases, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Zhang YY; Drug Discovery and Design Center, the Center for Chemical Biology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Zhou XR; Department of Gastroenterology, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 201210, China.
  • Sun ZY; Department of Analytical Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Xiao SH; Drug Discovery and Design Center, the Center for Chemical Biology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Wang HB; Drug Discovery and Design Center, the Center for Chemical Biology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Lu J; University of Chinese Academy of Sciences, Beijing, 100049, China.
  • Zhang NX; School of Life Science and Technology, Shanghai Tech University, Shanghai, 201210, China.
  • Jiang HL; Drug Discovery and Design Center, the Center for Chemical Biology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Chen KX; School of Life Science and Technology, Harbin Institute of Technology, Harbin, 200092, China.
  • Liu CP; Drug Discovery and Design Center, the Center for Chemical Biology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Zheng J; University of Chinese Academy of Sciences, Beijing, 100049, China.
  • Zhao KH; School of Life Science and Technology, Shanghai Tech University, Shanghai, 201210, China.
  • Luo C; School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, China.
Acta Pharmacol Sin ; 43(2): 470-482, 2022 Feb.
Article de En | MEDLINE | ID: mdl-33850276

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tanins hydrolysables / Glyceraldehyde 3-phosphate dehydrogenases Type d'étude: Prognostic_studies Limites: Animals / Humans / Male Langue: En Journal: Acta Pharmacol Sin Sujet du journal: FARMACOLOGIA Année: 2022 Type de document: Article Pays d'affiliation: Chine Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tanins hydrolysables / Glyceraldehyde 3-phosphate dehydrogenases Type d'étude: Prognostic_studies Limites: Animals / Humans / Male Langue: En Journal: Acta Pharmacol Sin Sujet du journal: FARMACOLOGIA Année: 2022 Type de document: Article Pays d'affiliation: Chine Pays de publication: États-Unis d'Amérique